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WHA acts on health regulations and intellectual property
Newsdesk WHO has been granted increased authority to deal with outbreaks of communicable diseases. The move was part of World Health Assembly (WHA) resolutions that urge greater collaboration on severe acute respiratory syndrome (SARS) and more intense efforts to conclude the revised International Health Regulations (IHRs).
WHO's annual assembly (May 19-28) declared that the organisation was "deeply concerned that SARS-as the first severe infectious disease to emerge in the 21st century-poses a serious threat to global health security, the livelihood of populations, the functioning of health systems, and the stability and growth of economies".
WHO voiced concern that the rapid spread of the virus had drawn attention to the inadequacy of the current health regulations.
Most importantly, the WHA called on WHO Director-General Gro Harlem Brundtland "to take into account reports from sources other than official notifications" in assessing potential international public-health threats.
WHA said WHO should collaborate with national authorities to assess the seriousness of any threat and "when necessary and after informing the government concerned, to conduct onthe-spot studies by a WHO team with the purpose of ensuring that appropriate control measures are being employed".
Brundtland said the resolution would give the agency a much firmer platform for action on potential global public-health risks. In particular, officials said it would help WHO to circumvent governments that are reluctant to report outbreaks and unwilling to grant speedy access to independent experts, as was initially the case with Chinese authorities and SARS.
The WHA also urged governments to establish national task forces and designate responsible officials who would be accessible at all times to ensure that emergencies would be speedily reported to WHO.
Director-General elect Jong-Wook Lee, whose appointment was confirmed by the assembly, said WHO would launch a US$200 million fund to reinforce its Global Outbreak and Alert Response Network.
The IHRs and SARS resolutions were unanimously approved on the final day of the assembly. During the debate top health officials from all SARS-affected countries-including China, Canada and Vietnam-spoke out for more effective international controls.
"The IHRs are outdated and belong to another time and age where infectious diseases which were dangerous to international health were a limited few", said Brundtland. "Here we have SARS illustrating that a public-health threat can come out of nowhere."
The IHRs are the only legally binding set of rules on global alert and response for infectious diseases. Last updated in 1981, they have serious shortcomings, not least because they class only cholera, plague, and yellow fever as notifiable diseases and do not reflect contemporary threats such as bioterrorism.
The revision is laborious because of the scope and complexity of the process, coupled with sensitivities over national sovereignty.
The USA, in particular, is watching carefully to ensure that the revised regulations do not conflict with its federal structure or constrain the action of the Centers for Didease Control and Prevention (CDC).
"If the acceleration in rules does not infringe upon our authority and leadership, then we will have no problem", said US Health and Human Services Secretary Tommy Thompson, when asked about the US position on the IHRs.
At a press conference on the eve of the WHA, Thompson repeatedly made it clear that he believed the CDC had a more important role on the global health stage than WHO. "The CDC is really the diamond", according to Thompson.
Thompson infuriated developing countries by submitting a resolution stressing the prime importance of intellectual property rights (IPRs) in innovation and public health. Brazil tabled a counter-resolution that health should have priority over trade.
After prolonged and bitter debate on IPRs, the WHA reached a compromise resolution. The resolution voiced concern that, of 1400 new products developed between 1975 and 1999, only 13 were for tropical disease and just three for tuberculosis. It pointed out that, although industrialised countries accounted for 90% of global pharmaceutical sales, 90% of the 14 million deaths due to infectious diseases happened in developing countries.
WHA urged WHO to support governments in the transfer of technology, giving high priority to antiretroviral drugs against HIV/AIDS, and to help monitor the public-health implications of trade agreements.
Most significantly, it said WHO should establish the terms of reference for an "appropriate time-limited body" to produce an analysis of IPRs, including the question of incentives for the creation of medicines that mainly affect the poor. Brazil, which has been pushing for WHO to exercise such a role, described this as a victory for developing countries.
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